Back
Oncternal Therapeutics Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
35
ONCT
Oncternal Therapeutics
Last Price:
1.19
Seasonality Move:
21.38%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCT is experiencing slight buying pressure.
Oncternal Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.47 | Sell |
| 20-day SMA: | 1.49 | Sell |
| 50-day SMA: | 1.86 | Sell |
| 200-day SMA: | 6.46 | Sell |
| 8-day EMA: | 1.43 | Sell |
| 20-day EMA: | 1.5 | Sell |
| 50-day EMA: | 2.19 | Sell |
| 200-day EMA: | 5.45 | Sell |
Oncternal Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 40.58 | Sell |
| Chaikin Money Flow: | 16399 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.2 - 1.66) | Sell |
| Bollinger Bands (100): | (1.55 - 6.55) | Sell |
Oncternal Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Oncternal Therapeutics Stock
Is Oncternal Therapeutics Stock a Buy?
- Oncternal Therapeutics share price is 1.29 while ONCT 8-day simple moving average is 1.47, which is a Sell signal.
- The stock price of ONCT is 1.29 while Oncternal Therapeutics 20-day SMA is 1.49, which makes it a Sell.
- Oncternal Therapeutics 50-day simple moving average is 1.86 while ONCT share price is 1.29, making it a Sell technically.
- ONCT stock price is 1.29 and Oncternal Therapeutics 200-day simple moving average is 6.46, creating a Sell signal.
ONCT Technical Analysis vs Fundamental Analysis
Sell
35
Oncternal Therapeutics (ONCT)
is a Sell
Is Oncternal Therapeutics a Buy or a Sell?
-
Oncternal Therapeutics stock is rated a Sell
The current Oncternal Therapeutics [ONCT] share price is $1.29. The Score for ONCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Oncternal Therapeutics Stock Info
Market Cap:
3.82M
Price in USD:
1.29
Share Volume:
82K
Oncternal Therapeutics 52-Week Range
52-Week High:
13.14
52-Week Low:
1.05
Sell
35
Oncternal Therapeutics (ONCT)
is a Sell
Oncternal Therapeutics Share Price Forecast
-
What is the Oncternal Therapeutics stock price today?
The Oncternal Therapeutics stock price is 1.29 USD today. -
Will ONCT stock go up or go down?
Oncternal Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Oncternal Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oncternal Therapeutics is overvalued.
Is Oncternal Therapeutics Stock a Buy?
- Oncternal Therapeutics share price is 1.29 while ONCT 8-day exponential moving average is 1.43, which is a Sell signal.
- The stock price of ONCT is 1.29 while Oncternal Therapeutics 20-day EMA is 1.50, which makes it a Sell.
- Oncternal Therapeutics 50-day exponential moving average is 2.19 while ONCT share price is 1.29, making it a Sell technically.
- ONCT stock price is 1.29 and Oncternal Therapeutics 200-day simple moving average is 5.45, creating a Sell signal.
Fundamental Analysis of Oncternal Therapeutics
Is Oncternal Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.51 per share, and an increase next year of $1.64 per share.
Technical Analysis of Oncternal Therapeutics
Should I short Oncternal Therapeutics stock?
- ONCT Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Oncternal Therapeutics is a Sell
- Oncternal Therapeutics Relative Strength Index (RSI) is 40.58, which suggest Oncternal Therapeutics is oversold
- The Bollinger Bands (25) for Oncternal Therapeutics is (1.2 - 1.66), which suggest Oncternal Therapeutics is a Sell
- The Bollinger Bands (100) for Oncternal Therapeutics is (1.55 - 6.55), which suggest Oncternal Therapeutics is a Sell
* Oncternal Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.